New Results
Human IgG neutralizing monoclonal antibodies block SARS-CoV-2 infection
Jinkai Wan, Shenghui Xing, Longfei Ding, Yongheng Wang, Dandan Zhu, Bowen Rong, Siqing Wang, Kun Chen, Chenxi He, Songhua Yuan, Chengli Qiu, Chen Zhao, Xiaoyan Zhang, Xiangxi Wang, Yanan Lu, Jianqing Xu, Fei Lan
doi: https://doi.org/10.1101/2020.05.19.104117
Jinkai Wan
1Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Shenghui Xing
1Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Longfei Ding
2Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
Yongheng Wang
3Active Motif China Inc., Shanghai, 201315, China
Dandan Zhu
4National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China
Bowen Rong
1Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Siqing Wang
1Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Kun Chen
1Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Chenxi He
1Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Songhua Yuan
2Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
Chengli Qiu
2Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
Chen Zhao
2Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
Xiaoyan Zhang
5Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai, 201508, China
Xiangxi Wang
4National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China
Yanan Lu
3Active Motif China Inc., Shanghai, 201315, China
Jianqing Xu
5Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai, 201508, China
Fei Lan
1Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Article usage
Posted May 28, 2020.
Human IgG neutralizing monoclonal antibodies block SARS-CoV-2 infection
Jinkai Wan, Shenghui Xing, Longfei Ding, Yongheng Wang, Dandan Zhu, Bowen Rong, Siqing Wang, Kun Chen, Chenxi He, Songhua Yuan, Chengli Qiu, Chen Zhao, Xiaoyan Zhang, Xiangxi Wang, Yanan Lu, Jianqing Xu, Fei Lan
bioRxiv 2020.05.19.104117; doi: https://doi.org/10.1101/2020.05.19.104117
Human IgG neutralizing monoclonal antibodies block SARS-CoV-2 infection
Jinkai Wan, Shenghui Xing, Longfei Ding, Yongheng Wang, Dandan Zhu, Bowen Rong, Siqing Wang, Kun Chen, Chenxi He, Songhua Yuan, Chengli Qiu, Chen Zhao, Xiaoyan Zhang, Xiangxi Wang, Yanan Lu, Jianqing Xu, Fei Lan
bioRxiv 2020.05.19.104117; doi: https://doi.org/10.1101/2020.05.19.104117
Subject Area
Subject Areas
- Biochemistry (11739)
- Bioengineering (8750)
- Bioinformatics (29189)
- Biophysics (14967)
- Cancer Biology (12093)
- Cell Biology (17409)
- Clinical Trials (138)
- Developmental Biology (9419)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18301)
- Genetics (12238)
- Genomics (16797)
- Immunology (11865)
- Microbiology (28068)
- Molecular Biology (11583)
- Neuroscience (60953)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4957)
- Plant Biology (10425)
- Synthetic Biology (2884)
- Systems Biology (7338)
- Zoology (1651)